Frontline Treatment of Chronic Myelogenous Leukemia
1 Views
administrator
06/27/23
There are currently three agents approved for the frontline treatment of patients with Philadelphia chromosome-positive chronic myelogenous leukemia, making an upfront treatment decision difficult. To address this, panelist explore possible first-line options and nuances of selecting therapies.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml
-
Category
Show more
Facebook Comments
No comments found